The BCC Research Blog

The sensor industry is a robust and booming business

Posted by Suman Sridhar

Jul 25, 2014 9:09:31 AM

From smart mobile communications to tablet PCs, sensors are indispensable assets in many different industries and applications. According to BCC Research's new report, Global Markets and Technologies for Sensors, they are largely used for converting data into measurable components.

Electronic control systems will increase the efficiency of sensors. Users of sensors call for advances in sensor accuracy, reliability, response time, and communication ability. As the report says, "The sensor industry is robust and is expected to experience sound growth during the next five years."


The dynamic automotive coatings markets and their growth factors

Posted by Suman Sridhar

Jul 22, 2014 3:42:33 PM

The global market for automotive coatings has changed significantly over the past decade, but for what reasons? One is the tenuous market which has affected the automotive industry. Additionally, there have been many changes in materials and process development, from conventional solvent coatings to more "green" options.

According to BCC Research's new report, Automotive Coatings: Technologies and Global Markets, a coating is a layer-forming substance that shields a substrate (i.e. surface or material) from potentially detrimental elements in its environment, as well as enhancing the substrate's appearance. Automotive coatings use different coatings according to the metals present in the body of a car.


The strong market potential for RNAi therapeutics

Posted by Suman Sridhar

Jul 16, 2014 11:06:08 AM

Since being discovered in 1998 by two scientists, the RNA interference (RNAi) effect has been hailed as the hottest technical breakthrough in biological research. RNAi is a technique that uses small portions of RNA to silence a cell's expression of genes and viruses that cause diseases. 



RNA interference (RNAi) is a natural biological process that cells use to inhibit the activity of specific genes, including those contributing to disease processes such as leukemia. Recent early-stage medical advances are enabling researchers to artificially trigger the RNAi mechanism  to disable individual genes.

These tools allow researchers to identify the functions the genes control and how they are effecting disease processes, thereby facilitating targeted drug development.  The work is at an early stage but its future potential has far-reaching implications.


Subscribe to Email Updates

All transactions on our web site are PayPal verified. All major cards accepted. No PayPal account needed.
Connect with BCC